These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 44 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 53%

Pfizer Inc News

Ocuphire Pharma Inc,Rocket Pharmaceuticals Inc,Arvinas Inc

Stocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket Pharmaceuticals Inc, Arvinas Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com

Often enough, some biotech stocks propel through expectations and invite investor frenzy. This week, it happened to Longeveron LLC . Owing to the prospective treatment of hypoplastic left heart syndrome in the Phase 2 trial, the clinical-stage firm gained a 234% value boost over the week.

Simply put, this pioneering platform degrades proteins linked to many serious and rare diseases. Arvinas uses its Protac Discovery Engine platform to develop a drug pipeline in oncology, immuno-oncology, and pro-inflammatory rare diseases. Ocuphire’s retina drug pipeline is in the exploratory stage. The company has APX2009 for geographic atrophy and APX2014 as the second-generation drug for the treatment of retinal diseases such as age-related macular degeneration. Ocuphire will start ZETA-2 Phase 2/3 trials for APX3330 in early 2025.

The company, which is mainly focused on hematology and cardiovascular , filed a Marketing Authorisation Application for its LV RP-L102 to treat Fanconi anemia. On June 30th, the FDA is scheduled to respond to the company’s application for LV KRESLADI for the treatment of severe Leukocyte Adhesion deficiency-I .

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

3 Top Stocks in the Dow Jones Worth Holding in 2024Stocks Analysis by The Tokenist (Timothy Fries) covering: Dow Jones Industrial Average, Caterpillar Inc, Microsoft Corporation, Alphabet Inc Class A. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Stocks to Watch Today: J.M. Smucker, PayPal, Lululemon AthleticaStocks Analysis by The Tokenist (Timothy Fries) covering: JM Smucker Company, Lululemon Athletica Inc, PayPal Holdings Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

Stocks to Watch Today: Apple, Gamestop, and First SolarStocks Analysis by The Tokenist (Timothy Fries) covering: Apple Inc, First Solar Inc, GameStop Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »

These 3 Stocks Can Surge if the Fed Cuts Rates in SeptemberStocks Analysis by The Tokenist (Timothy Fries) covering: NVIDIA Corporation, Advanced Micro Devices Inc, Natural Gas Futures, Essential Utilities Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Source: Investingcom - 🏆 450. / 53 Read more »